IM Cannabis Corp. (IMCC) vs Redhill Biopharma Ltd. (RDHL)
- IM Cannabis Corp. IMCC 1.36 +2.26%
- Redhill Biopharma Ltd. RDHL 0.48 −4.00%
IM Cannabis Corp. and Redhill Biopharma Ltd. are both Drug Manufacturers Specialty & Generic companies. Redhill Biopharma Ltd. is the larger, with a market value of $4.4M against $2.2M — 2.0× the size. IM Cannabis Corp. grew revenue faster over the last twelve months: −12.0% against −61.9%. Redhill Biopharma Ltd. has the higher net margin (25.2% vs −38.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, IM Cannabis Corp. leads on 9 and Redhill Biopharma Ltd. on 7.
Valuation
| Metric | IMCC | RDHL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 19.25 |
| P/S | 0.01 | 0.00 | 2.11 |
| P/B | n/m | n/m | 1.78 |
| Price to free cash flow | n/m | n/m | 16.14 |
| EV/EBITDA | n/m | n/m | 12.58 |
| EV/Sales | 0.00 | 6.43 | 2.73 |
| Earnings yield | (5,660.48%) | (127,222.23%) | (4.38%) |
| Free cash flow yield | (115.96%) | (246,986.61%) | 0.00% |
Profitability
| Metric | IMCC | RDHL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 12.62% | 35.16% | 53.94% |
| Operating margin | (32.88%) | 0.00% | 0.00% |
| Net margin | (38.92%) | 25.20% | 0.00% |
| Free cash flow margin | (1.47%) | 0.00% | 0.00% |
| Return on equity | 2,280.06% | 0.00% | (0.40%) |
| Return on assets | (54.20%) | 0.00% | (3.32%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack